Why are there so many drug shortages?

Anesth Prog

Published: October 2010

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315272PMC
http://dx.doi.org/10.2344/0003-3006-57.3.89DOI Listing

Publication Analysis

Top Keywords

drug shortages?
4
drug
1

Similar Publications

Prosthetic valve endocarditis (PVE) is the medical term used to describe a focus of infection involving a valvular substitute within the heart. It is a significant concern in the field of cardiology, and the epidemiology of PVE has seen notable developments over the last five decades. The disease currently affects an older demographic and is becoming increasingly prevalent in patients with transcatheter-implanted valves.

View Article and Find Full Text PDF

The prevalence and consequences of support for off-label Ozempic prescriptions.

Health Econ Policy Law

January 2025

Department of Political Science, Texas A&M University, College Station, TX, USA.

Ozempic and related semaglutide drugs represent a popular new strategy to address obesity in the United States, yet uptake of these medications has sparked opposition highlighting concerns about off-label drug use policies, drug safety, supply shortages and cost. Public attitudes towards off-label prescribing by physicians broadly, and towards Ozempic in particular, in light of this opposition are unclear. To better understand public sentiment on this topic, we analysed data from a representative survey of 3,420 US adults conducted from 13 to 22 June 2023.

View Article and Find Full Text PDF

Intrauterine growth restriction (IUGR) caused by placental dysfunctions leads to fetal growth defects. Maternal microbiome and its metabolites have been reported to promote placental development. Milk fat globule membrane (MFGM) is known for its diverse bioactive functions, while the effects of gestational MFGM supplementation on the maternal gut microbiota, placental efficiency, and fetal development remained unclear.

View Article and Find Full Text PDF

[Prospects for the development of new drugs for the treatment of osteoporosis].

Zhonghua Yi Xue Za Zhi

January 2025

Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing100730, China.

With the population aging, the prevalence of osteoporosis is rapidly increasing, which has become serious public health problem. At present, there is a severe shortage of effective anti-osteoporotic drugs in China, making it difficult to control the growing trend of osteoporosis. The key pathological mechanism of osteoporosis is bone homeostasis imbalance.

View Article and Find Full Text PDF

Long-term forecast for antibacterial drug consumption in Germany using ARIMA models.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Hannover Medical School, Institute of Pharmacology, D-30625, Hannover, Germany.

Article Synopsis
  • This study forecasts the consumption of the top ten antibacterial drugs in Germany until 2040, using historical prescription data and ARIMA models.
  • The best model for forecasting is a simple random walk with drift (ARIMA(0,1,0)), while short-term predictions show minimal variation among complex models.
  • Predictions indicate rising prescriptions for some drugs like amoxicillin, but declines for others, emphasizing the need for proactive healthcare planning to address potential shortages.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!